The potential mechanisms involved in dysregulated FGFR4 signaling cascades in Taiwanese patients with lung adenocarcinoma, particularly those with the wild-type EGFR gene, warrant further exploration. The gene discussed is EGFR; the disease is lung adenocarcinoma.